October 28, 2020
Company manufacturing and distributing D-Fi at in-house, cGMP commercial-scale facility in greater Philadelphia area
Read MoreOctober 15, 2020
Study targets a chronic autoimmune skin disorder affecting approximately 50,000 patients in the U.S.
Read MoreMarch 25, 2020
Leveraging proprietary technology and manufacturing platform to develop transformative gene therapies for multiple rare diseases with high unmet needs
Read More